Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NITA: Islet Transplantation with ATG, Cyclosporine, and Everolimus
NCT00286624Phase 2Completed
- Sponsor
- University of Minnesota
- Start
- Mar 2003
- Primary completion
- Aug 2006
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of donislecel in type 1 diabetes mellitus (T1D), sponsored by University of Minnesota. Started Mar 2003; status: completed.
02
Drugs
donislecel
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00286624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00286624.